Prostate Cell News Volume 15.18 | Jul 26 2024

    0
    96







    2024-07-26 | PCN 15.18


    Prostate Cell News by STEMCELL Technologies
    Vol. 15.18 – 26 July, 2024
    TOP STORY

    Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial

    Researchers determined if Stockholm3 could improve prostate cancer detection in a diverse cohort. An observational prospective multicentered clinical trial, supplemented by prospectively recruited participants in a urology clinic setting included men with suspicion of prostate cancer and underwent prostate biopsy.
    [Journal of Clinical Oncology]

    AbstractPress Release
    People's Choice Podcast Award
    PUBLICATIONSRanked by the impact factor of the journal

    Notch Signaling Suppresses Neuroendocrine Differentiation and Alters the Immune Microenvironment in Advanced Prostate Cancer

    While Notch could be oncogenic in early prostate cancer, scientists identified significant downregulation of the Notch pathway during prostate cancer progression from adenocarcinoma to neuroendocrine prostate cancer where it functioned as a tumor suppressor.
    [Journal of Clinical Investigation]

    AbstractGraphical Abstract

    USP11 Promotes Prostate Cancer Progression by Up-Regulating AR and c-Myc Activity

    Investigators found that the deubiquitinase USP11 targeted both androgen receptor and c-Myc in prostate cancer (PCa). USP11 expression was up-regulated in metastatic PCa and castration-resistant prostate cancer.
    [Proceedings of The National Academy of Sciences of The United States of America]

    Abstract

    Targeting Valine Catabolism to Inhibit Metabolic Reprogramming in Prostate Cancer

    Through the suppression of branched-chain amino acid (BCAA) availability, researchers reported significantly reduced lipid content, strongly indicating that BCAAs were important lipogenic fuels in prostate cancer.
    [Cell Death & Disease]

    Full ArticleGraphical Abstract

    The PP2A Regulator IER5L Supports Prostate Cancer Progression

    The authors showed that the less studied member of the Immediate Early Response (IER) family, IER 5 like (IER5L), was upregulated in aggressive prostate cancer.
    [Cell Death & Disease]

    Full Article

    Effects of Protein Restriction on Insulin-Like Growth Factor (IGF)-1 in Men with Prostate Cancer: Results from a Randomized Clinical Trial

    Researchers demonstrated that protein restriction without calorie restriction did not reduce serum IGF-1 concentration or increase IGFBP-1 and IGFBP-3 in men with localized prostate cancer.
    [Biomarker Research]

    Full Article

    Clinical Implications of Wnt Pathway Genetic Alterations in Men with Advanced Prostate Cancer

    Investigators utilized the Prostate Cancer Precision Medicine Multi-Institutional Collaborative Effort clinical-genomic database for this retrospective analysis.
    [Prostate Cancer and Prostatic Diseases]

    Abstract
    Wallchart: Reporting practices for publishing results with hPSCs. Request a copy.
    REVIEWS

    Epitranscriptomic Mechanisms of Androgen Signaling and Prostate Cancer

    Given the need for novel approaches to treat PCa (prostate cancer), there is significant interest in new therapies that target m6A that modulate androgen receptor expression and androgen signaling. This review critically summarizes the potential benefit of such epitranscriptomic therapies for PCa patients.
    [Neoplasia]

    Full Article
    INDUSTRY AND POLICY NEWS

    Blue Earth Therapeutics Announces Clinical Research Collaboration with UCL to Develop Innovative Alpha-Labelled Radioligand Therapy (RLT) for Prostate Cancer

    Blue Earth Therapeutics announced a clinical research collaboration with University College London (UCL) to evaluate the safety, tolerability, radiation dosimetry, and anti-tumor activity of the company’s 225Ac-rhPSMA-10.1 in men with metastatic castrate-resistant prostate cancer.
    [Blue Earth Therapeutics]

    Press Release
    FEATURED EVENT

    Engineering Development and Disease in Organoids

    August 19 – 21, 2024
    San Diego, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Senior Medical Director – Prostate Cancer

    Pfizer – York New Salem, Pennsylvania, United States

    Scientific Research Fellowship – Biological Sciences

    University of Algarve – Faro, Portugal

    Director – Office of Cancer Centers

    National Cancer Institute – Bethesda, Maryland, United States

    Postdoctoral Positions – Biochemistry

    Goethe University Frankfurt am Main – Frankfurt, Germany

    Professor – Science Research

    KU Leuven – Leuven, Belgium

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2